business

Moleculin Biotech secures Hong Kong patent for Annamycin

Investing.com · May 8, 2026, 12:53 PM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

The Guardian Hong Kong dissident Nathan Law on China spies in UK: ‘We’re not surprised’ Yahoo Finance New World considers divestment of $2bn hotel portfolio in Hong Kong Bloomberg Tech Baidu’s AI Chip Unit Plans Dual IPO in Shanghai and Hong Kong Euronews UK to summon Chinese ambassador after convictions over spying on Hong Kong dissidents

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Moleculin Biotech secures Hong Kong patent for Annamycin

Also covered by

More in business